28 search results for Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma, NCCN clinical practice guidelines in oncology – Pancreatic Adenocarcinoma
https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdfNCCN Guidelines Pancreatic Adenocarcinoma
NCCN Guidelines Pancreatic Adenocarcinoma, NCCN clinical practice guidelines in oncology – Pancreatic Adenocarcinoma
https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdfImaging AUC Compendium Reviewer Acknowledgement
Pancreatic Adenocarcinoma Jared A. Christensen, MD, reviewed in 2024 for contributing their time and expertise: Ampullary Adenocarcinoma, Assessment: Breast, Ovarian, Pancreatic, and Prostate Tuya Pal, MD
https://www.nccn.org/compendia-templates/compendia/imaging-appropriate-use-criteria-nccn-imaging-auc/imaging-auc-compendium-reviewer-acknowledgementBiomarkers Compendium Reviewer Acknowledgment
Moffitt Cancer Center Pancreatic Adenocarcinoma Elena, Adenocarcinoma Elena Gabriela G. Chiorean, MD Fred, : Breast, Ovarian, Pancreatic, and Prostate Mary B. Daly, PhD, MD, Kettering Cancer Center Small Bowel Adenocarcinoma Kristen K
https://www.nccn.org/compendia-templates/compendia/biomarkers-compendium/biomarkers-compendium-reviewer-acknowledgmentPermission to Cite or Use NCCN Content
Palliative Care Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia Pediatric Aggressive, Cancer Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia Pediatric Aggressive Mature B, Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Palliative Care Pancreatic Adenocarcinoma, Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia, Leukemia Adolescent and Young Adult (AYA) Oncology Adult Cancer Pain Ampullary Adenocarcinoma
https://www.nccn.org/guidelines/permission-to-cite-or-use-nccn-contentRadiation Therapy Compendium Reviewer Acknowledgement
Pancreatic Adenocarcinoma Brian Czito, MD, Cancer Center Ampullary Adenocarcinoma Brian Czito, MD
https://www.nccn.org/compendia-templates/compendia/radiation-therapycompendium/radiation-therapy-compendium-reviewer-acknowledgementResume Screening
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric, Adenocarcinoma Anal Carcinoma Basal Cell Skin Cancer B-Cell Lymphomas Biliary Tract Cancers, Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma, Colorectal Cancer Screening Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, , Pancreatic, and Prostate Cancers Graft-Versus-Host Disease Hodgkin Lymphoma - Hodgkin Lymphoma
https://www.nccn.org/covid-19/resume-screeningTransparency Process
/Attendance Version: 2.2025 ( Small Bowel Adenocarcinoma ) Date: 2025-01-14 Transparency, ( Small Bowel Adenocarcinoma ) Date: 2024-08-29 Transparency Panel Disclosures/Attendance, ( Small Bowel Adenocarcinoma ) Date: 2024-06-21 Transparency Panel Disclosures, Disclosures/Attendance Version: 3.2024 ( Small Bowel Adenocarcinoma ) Date: 2024-04-17, Bowel Adenocarcinoma ) Date: 2024-02-09 Transparency Panel Disclosures/Attendance
https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendationsGuidelines Panels
Panel Pancreatic Adenocarcinoma Panel, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel
https://www.nccn.org/guidelines/guidelines-panels-and-disclosure/disclosure-panelsTreatment by Cancer Type
Version: 2.2025 Ampullary Adenocarcinoma, Cancer Version: 1.2025 Pancreatic Adenocarcinoma Version: 2.2025 Pediatric Acute, Small Bowel Adenocarcinoma Version: 3.2025
https://www.nccn.org/guidelines/category_1Current Opportunities
Ampullary Adenocarcinoma Anal Carcinoma Basal Cell Skin Cancer B-Cell Lymphomas Biliary Tract, Occult Primary Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia Pediatric Aggressive Mature B-Cell Lymphomas, Lymphomas Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft, , Pancreatic, and Prostate Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric
https://www.nccn.org/education-research/nccn-oncology-research-program/current-opportunitiesSubmission Request Form
Palliative Care - 2.2025 Pancreatic Adenocarcinoma - 2.2025 Pediatric Acute Lymphoblastic Leukemia, Adolescent and Young Adult (AYA) Oncology - 2.2025 Adult Cancer Pain - 1.2025 Ampullary Adenocarcinoma, High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate - 3.2025 Genetic/Familial High-Risk, Prostate Cancer Early Detection - 1.2025 Rectal Cancer - 2.2025 Small Bowel Adenocarcinoma
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-formHIT
Leukemia Ampullary Adenocarcinoma Anal Carcinoma Basal Cell Skin Cancer B-Cell Lymphomas Biliary, Cancer Occult Primary Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia Pediatric Aggressive Mature B-Cell Lymphomas, Cutaneous Lymphomas Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer, , Ovarian, Pancreatic, and Prostate Genetic/Familial High-Risk Assessment: Colorectal, Endometrial
https://www.nccn.org/redirects/hitRecently Updated Guidelines
Rectal Cancer Version 2.2025 Small Bowel Adenocarcinoma Version 3.2025 Soft, Version 2.2025 Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic
https://www.nccn.org/guidelines/recently-published-guidelinesGuidelines for Patients
Pancreatic Cancer Version: 2023, Small Bowel Adenocarcinoma Version: 2024, Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patientsGuidelines for Patients
Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers, Version: 2023 Pancreatic Cancer, Version: 2024 Small Bowel Adenocarcinoma
https://www.nccn.org/guidelines/patientsHarmonized Guidelines
Version 2.2023 Pancreatic Adenocarcinoma Version 2.2022 Pediatric Acute
https://www.nccn.org/global/what-we-do/harmonized-guidelinesTreatment by Cancer Type
: 2024 Pancreatic Cancer Version: 2023, : 2024 Small Bowel Adenocarcinoma Version, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/treatment-by-cancer-typeDetection, Prevention, and Risk Reduction
: 2024 Pancreatic Cancer Version: 2023, : 2024 Small Bowel Adenocarcinoma Version, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/detection-prevention-and-risk-reductionSupportive Care
: 2024 Pancreatic Cancer Version: 2023, : 2024 Small Bowel Adenocarcinoma Version, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/supportive-care